BIOMAT Database Logo BIOMAT Database Logo

Plasma concentrations and bioavailability of clofibrate after administration to human subjects. 1974

L F Chasseaud, and A J Cooper, and V H Saggers

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D001702 Biopharmaceutics The study of the physical and chemical properties of a drug and its dosage form as related to the onset, duration, and intensity of its action. Pharmaceutics,Pharmaceutic

Related Publications

L F Chasseaud, and A J Cooper, and V H Saggers
Isosorbide dinitrate plasma concentrations and bioavailability in human subjects after administration of standard oral and sublingual formulations.
May 1984, Journal of pharmaceutical sciences,
L F Chasseaud, and A J Cooper, and V H Saggers
Plasma protein concentrations in hypertriglyceridaemic subjects. Effect of clofibrate and comparison with normal subjects.
July 1978, Clinica chimica acta; international journal of clinical chemistry,
L F Chasseaud, and A J Cooper, and V H Saggers
Plasma concentrations of isosorbide dinitrate after oral administration of a sustained-release formulation to human subjects.
January 1977, Arzneimittel-Forschung,
L F Chasseaud, and A J Cooper, and V H Saggers
Plasma isosorbide dinitrate concentrations in human subjects after administration of standard and sustained-release formulations.
June 1977, Journal of pharmaceutical sciences,
L F Chasseaud, and A J Cooper, and V H Saggers
Plasma and urine aluminium concentrations in healthy subjects after administration of sucralfate.
April 1990, British journal of clinical pharmacology,
L F Chasseaud, and A J Cooper, and V H Saggers
Plasma concentrations of isosorbide dinitrate after administration of increasing doses of a sustained-release formulation to human subjects.
January 1978, Arzneimittel-Forschung,
L F Chasseaud, and A J Cooper, and V H Saggers
Absolute bioavailability of imidafenacin after oral administration to healthy subjects.
February 2008, British journal of clinical pharmacology,
L F Chasseaud, and A J Cooper, and V H Saggers
Use of high-performance liquid chromatography to measure plasma concentrations of p-chlorophenoxyisobutric acid after administration of clofibrate to humans.
July 1977, Journal of chromatography,
L F Chasseaud, and A J Cooper, and V H Saggers
Plasma concentrations of megestrol acetate and medroxyprogesterone acetate after single oral administration to healthy subjects.
January 1983, Journal of pharmaceutical and biomedical analysis,
L F Chasseaud, and A J Cooper, and V H Saggers
Plasma concentrations of isosorbide dinitrate after cutaneous and sublingual doses to human subjects.
January 1978, Journal of clinical pharmacology,
Copied contents to your clipboard!